Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta

Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta

Abstract Background Children with osteogenesis imperfecta (OI) experience pain and impaired physical functioning. The longitudinal effect of cyclic bisphosphonate treatment on these symptoms has not been described. We serially evaluated pain and functioning in pediatric patients with OI treated with...

Full description

Bibliographic Details
Main Authors: Melissa D. Garganta, Sarah S. Jaser, Margot A. Lazow, Jonathan G. Schoenecker, Erin Cobry, Stephen R. Hays, Jill H. Simmons
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Musculoskeletal Disorders
Subjects:
Osteogenesis imperfecta
Bisphosphonate
Pamidronate
Zoledronic acid
Pain
Faces®
Online Access:http://link.springer.com/article/10.1186/s12891-018-2252-y

Internet

http://link.springer.com/article/10.1186/s12891-018-2252-y

Similar Items